SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/25/21 Tenet Healthcare Corp. 8-K:5 1/22/21 11:170K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 24K 7: R1 Document and Entity Information HTML 50K 9: XML IDEA XML File -- Filing Summary XML 12K 6: XML XBRL Instance -- d98795d8k_htm XML 18K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.DEF XBRL Definitions -- thc-20210122_def XML 40K 4: EX-101.LAB XBRL Labels -- thc-20210122_lab XML 65K 5: EX-101.PRE XBRL Presentations -- thc-20210122_pre XML 41K 2: EX-101.SCH XBRL Schema -- thc-20210122 XSD 15K 10: JSON XBRL Instance as JSON Data -- MetaLinks 14± 21K 11: ZIP XBRL Zipped Folder -- 0001193125-21-016277-xbrl Zip 10K
8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: i January 22, 2021
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
i Nevada | i 1-7293 | i 95-2557091 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
i 14201 Dallas Parkway
i Dallas, i Texas i 75254
(Address of principal executive offices, including zip code)
i (469) i 893-2200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading symbols |
Name of each exchange on which registered | ||
i Common stock $0.05 par value | i THC | i New York Stock Exchange | ||
i 6.875% Senior Notes due 2031 | i THC31 | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Following his confirmation by the U.S. Senate as Secretary of the U.S. Department of Defense on January 22, 2021, General Lloyd J. Austin III, a member of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”), notified the Company of his decision to resign from the Board effective January 22, 2021. The size of the Board decreased to 11 at such time. General Austin’s resignation did not result from any disagreement with the Company or the Board.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TENET HEALTHCARE CORPORATION | ||||||
Date: January 25, 2021 | ||||||
By: | /s/ Audrey Andrews | |||||
Name: | Audrey Andrews | |||||
Title: | Executive Vice President, General Counsel and Corporate Secretary |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 1/25/21 | None on these Dates | ||
For Period end: | 1/22/21 | |||
List all Filings |